USA - NASDAQ:AMRS - US03236M2008 - Common Stock
The current stock price of AMRS is 0.05 USD. In the past month the price decreased by -94.62%. In the past year, price decreased by -98.26%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SHW | SHERWIN-WILLIAMS CO/THE | 29.5 | 83.19B | ||
| ECL | ECOLAB INC | 34.81 | 71.77B | ||
| PPG | PPG INDUSTRIES INC | 12.39 | 21.48B | ||
| DD | DUPONT DE NEMOURS INC | 8.96 | 16.40B | ||
| IFF | INTL FLAVORS & FRAGRANCES | 14.38 | 16.11B | ||
| RPM | RPM INTERNATIONAL INC | 19.83 | 13.58B | ||
| ALB | ALBEMARLE CORP | N/A | 10.74B | ||
| NEU | NEWMARKET CORP | 16.14 | 7.18B | ||
| EMN | EASTMAN CHEMICAL CO | 9.15 | 6.85B | ||
| ESI | ELEMENT SOLUTIONS INC | 18.21 | 6.47B | ||
| AXTA | AXALTA COATING SYSTEMS LTD | 11.29 | 6.11B | ||
| BCPC | BALCHEM CORP | 30.63 | 4.94B |
Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 1,598 full-time employees. The company went IPO on 2010-09-28. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The firm leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.
AMYRIS INC
5885 Hollis St Ste 100
Emeryville CALIFORNIA 94608 US
CEO: John G. Melo
Employees: 1598
Phone: 15104500761.0
Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 1,598 full-time employees. The company went IPO on 2010-09-28. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The firm leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.
The current stock price of AMRS is 0.05 USD. The price decreased by -21.87% in the last trading session.
AMRS does not pay a dividend.
AMRS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
14 analysts have analysed AMRS and the average price target is 1.74 USD. This implies a price increase of 3384.94% is expected in the next year compared to the current price of 0.05.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AMRS.
AMYRIS INC (AMRS) currently has 1598 employees.
ChartMill assigns a fundamental rating of 1 / 10 to AMRS. AMRS may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months AMRS reported a non-GAAP Earnings per Share(EPS) of -1.67. The EPS decreased by -595.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
14 analysts have analysed AMRS and the average price target is 1.74 USD. This implies a price increase of 3384.94% is expected in the next year compared to the current price of 0.05.
For the next year, analysts expect an EPS growth of 67.21% and a revenue growth 76.61% for AMRS